The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 4 , Pages 1039-1040 , October 2009

Latest information for the thoracic surgeon from the Annual Meeting of the American Society of Clinical Oncology

  • Sarita Dubey, MD

      Affiliations

    • University of California San Francisco, San Francisco, Calif
    • Corresponding Author InformationAddress for reprints: Sarita Dubey, MD, University of California San Francisco, 1600 Divisadero St, Rm A 742, San Francisco, CA 94115.
    • ,
  • Giorgio Scagliotti, MD, PhD

      Affiliations

    • Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano (Torino), Italy

References 

  1. Allen JW, Osarogiagbon R, Farooq A, Ninan M, O'Brien TF. Quality of surgical resection for non-small cell lung cancer (NSCLC) in a U.S. metropolitan area. [abstract] J Clin Oncol. 2009;27(15S):385S
  2. Osarogiagbon RU, Allen JW, Farooq A, Ninan M, Ratliff TW. Outcome of surgical resection for pathologic Nx and N0 non-small cell lung cancer (NSCLC). [abstract] J Clin Oncol. 2009;27(15S):385S
  3. Grilley-Olson JE, Hayes DN, Qaqish BF, Moore DT, Socinski MA, Yin X, et al. Diagnostic reproducibility of squamous cell carcinoma (SC) in the era of histology-directed non-small cell lung cancer (NSCLC) chemotherapy: a large prospective study. J Clin Oncol. 2009;27(15S):409S
  4. Kohman L, Watson D, Herndon J, Eves N, Haithcock B, Loewen G, et al. CALGB 140803—association between cardiorespiratory fitness and overall survival in operable lung cancer patients: ancillary analysis of protocol 9238. J Clin Oncol. 2009;27(15S):386S
  5. Fouret P, Planchard D, Mendiboure J, Kamal NS, Olaussen KA, Bertrand P, et al. MSH2 and adjuvant cisplatin-based chemotherapy in non-small cell lung cancer. J Clin Oncol. 2009;27(18S):806S
  6. Felip E, Massuti B, Alonso G, González-Larriba JL, Camps C, Isla D, et al. Surgery (S) alone, preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy followed by S, or S followed by adjuvant (adj) PC chemotherapy in early-stage non-small cell lung cancer (NSCLC): results of the NATCH multicenter, randomized phase III trial. J Clin Oncol. 2009;27(15S):382S
  7. Vincent MD, Butts C, Seymour L, Ding K, Graham B, Twumasi-Ankrah P, et al. Updated survival analysis of JBR.10: a randomized phase III trial of vinorelbine/cisplatin versus observation in completely resected stage IB and II non-small cell lung cancer (NSCLC). J Clin Oncol. 2009;27(15S):382S
  8. Gore EM, Bae K, Wong S, Bonner J, Sun A, Schild S, et al. A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: initial analysis of Radiation Therapy Oncology Group 0214. J Clin Oncol. 2009;27(15S):383S

PII: S0022-5223(09)00924-6

doi: 10.1016/j.jtcvs.2009.07.004

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 4 , Pages 1039-1040 , October 2009

Article Tools

* Image Usage & Resolution